NCT00494559View on ClinicalTrials.gov

The Effect of Pioglitazone on Neointima Volume and Inflammatory Markers

PHASE4CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2015

Conditions
Diabetes MellitusCoronary Artery Stenosis
Interventions
DRUG

Pioglitazone

Actos 15mg once a day before breakfast

DRUG

Placebo

Placebo drug with the same appearance as actos

Trial Locations (1)

136-705

Korea University Anam Hospital, Seoul

All Listed Sponsors
lead

Korea University Anam Hospital

OTHER

NCT00494559 - The Effect of Pioglitazone on Neointima Volume and Inflammatory Markers | Biotech Hunter | Biotech Hunter